Latest Safety News

SG Fleet Group reported a solid $41.1 million NPAT for the first half of 2025, driven by strong disposal volumes and fleet growth across Australia, New Zealand, and the UK. While profit dipped from last year, the company anticipates normalization in the second half.

MLG Oz Limited has secured a significant $75 million haulage contract with Westgold Resources, poised to generate over $25 million annually and deepen its footprint in Western Australia's Goldfields region.

Opthea has completed the final patient visit in its pivotal COAST Phase 3 trial evaluating sozinibercept combined with aflibercept for wet AMD, with topline results expected early Q2 2025.

Monadelphous Group Ltd reported a robust first half of FY2025 with revenue climbing 4.2% to $1.051 billion and net profit after tax surging 41.3%, underpinned by a strong contract pipeline and operational improvements.

Monadelphous delivered a robust first half in 2025, posting a 4.2% revenue increase to $1.051 billion and a 41.3% jump in net profit after tax, underpinned by strong contract wins and operational momentum.

Icetana Limited has successfully closed its renounceable pro rata entitlement offer, raising $629,422 through new share issuance, with convertible notes poised to convert into shares shortly.

Variscan Mines reports strong progress in its maiden underground drilling at the Udias Mine, with assay results expected soon, while advancing critical studies for a mine restart at its Novales-Udias Project.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

HyTerra Limited faces operational delays at its Nemaha Project due to severe winter weather but strengthens its management team with a key executive hire to drive 2025 exploration forward.

Artemis Resources has clarified the permitting status of its Radio Hill processing plant and outlined the regulatory and operational steps required to resume processing activities, while granting Greentech Metals an exclusive option to assess copper ore feasibility.

Recce Pharmaceuticals reports strong Phase II results for its RECCE® 327 topical gel, achieving a 93% efficacy rate in treating serious skin infections and setting the stage for accelerated Phase 3 trials.

White Cliff Minerals has awarded drilling contracts to Northspan Explorations for a 4,000-meter campaign at its Rae Copper Project in Nunavut, marking a significant exploration push after decades of dormancy.